Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin
Clinical trial NCT02963922 · COMPLETED
Trial details
- NCT number
- NCT02963922
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-06
- Primary completion
- 2018-09-10
- Enrollment
- 396
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.